Catalyst Property Plant And Equipment Gross from 2010 to 2024

CPRX Stock  USD 21.97  0.14  0.63%   
Catalyst Pharmaceuticals Property Plant And Equipment Gross yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Gross is likely to outpace its year average in 2024. During the period from 2010 to 2024, Catalyst Pharmaceuticals Property Plant And Equipment Gross regression line of annual values had r-squared of  0.67 and arithmetic mean of  1,256,781. View All Fundamentals
 
Property Plant And Equipment Gross  
First Reported
2004-12-31
Previous Quarter
4.5 M
Current Value
4.7 M
Quarterly Volatility
1.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Catalyst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5 M, Other Operating Expenses of 327 M or Operating Income of 91.2 M, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0 or PTB Ratio of 4.38. Catalyst financial statements analysis is a perfect complement when working with Catalyst Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Catalyst Pharmaceuticals Correlation against competitors.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

Latest Catalyst Pharmaceuticals' Property Plant And Equipment Gross Growth Pattern

Below is the plot of the Property Plant And Equipment Gross of Catalyst Pharmaceuticals over the last few years. It is Catalyst Pharmaceuticals' Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catalyst Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Gross10 Years Trend
Slightly volatile
   Property Plant And Equipment Gross   
       Timeline  

Catalyst Property Plant And Equipment Gross Regression Statistics

Arithmetic Mean1,256,781
Geometric Mean228,092
Coefficient Of Variation146.74
Mean Deviation1,551,890
Median191,549
Standard Deviation1,844,159
Sample Variance3.4T
Range4.6M
R-Value0.82
Mean Square Error1.2T
R-Squared0.67
Significance0.0002
Slope337,009
Total Sum of Squares47.6T

Catalyst Property Plant And Equipment Gross History

20244.6 M
20234.4 M
20223.6 M
2021M
2020129.8 K
2019M
2018245.4 K

About Catalyst Pharmaceuticals Financial Statements

Catalyst Pharmaceuticals investors use historical fundamental indicators, such as Catalyst Pharmaceuticals' Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Catalyst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Gross4.4 M4.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.